Table 2.
Gene differential expression at inclusion between future good and poor responders to amisulpride treatment.
| Gene name | Difference between Future good and poor responders at inclusion | ||
|---|---|---|---|
| FC | p value | FDR | |
| ALPL | 1.32 | 0.003 | 0.02 |
| DHRS13 | 1.18 | 0.003 | 0.02 |
| HOMER3 | 1.18 | 0.01 | 0.04 |
| DGAT2 | 1.15 | 0.02 | 0.04 |
| WLS | 1.16 | 0.05 | 0.08 |
| CA4 | 1.16 | 0.05 | 0.08 |
| GALNT14 | 1.16 | 0.13 | 0.19 |
| ACSL5 | 0.99 | 0.62 | 0.78 |
| KIAA0319 | 1.02 | 0.75 | 0.84 |
| KAZN | 1.00 | 0.97 | 0.97 |
Significant p values resisting to a Benjamini–Hochberg false discovery rate (FDR) of 0.1 are shown in bold. FC expression fold change.